Skip to main content
Have a personal or library account? Click to login
Compatibility studies of nateglinide with excipients in immediate release tablets Cover

Compatibility studies of nateglinide with excipients in immediate release tablets

By: ,   and    
Open Access
|Jun 2011

References

  1. R. K. Verma and S. Garg, Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations,(2004) 449-458; DOI: 10.1016/j.jpba.2004.01.012.
  2. E. C. V. Tonder, A. P. Lotter and S. A. Botha, Compatibility study between doxylamine succinate with other drugs and excipients using differential scanning calorimetry,(1990) 2125-2133; DOI: 10.3109/03639049009023644.
  3. S. Venkataram, M. Khohlokwane and S. H. Wallis, Differential scanning calorimetry as a quick scanning technique for solid state stability studies,(1995) 847-855; DOI: 10.3109/03639049509026649.
  4. R. Kandarapu, V. Grover, H. P. S. Chawla and S. Garg, Evaluation of compatibility of ketorolac tromethamine with selected polymers and common tablet excipients by thermal and isothermal stress testing,(2001) 449-457.
  5. P. Mura, A. Manderioli, G. Bramanti, S. Furlanetto and S. Pinzauti, Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients,(1995) 71-79; DOI: 10.1016/0378-5173(94)00374.
  6. P. Mura, M. T. Faucci, A. Manderioli, G. Bramanti and L. Ceccarelli, Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy,(1998) 151-163; DOI: 10.1016/S0731-7085(98)00171.
  7. S. A. Botha and A. P. Lotter, Compatibility study between naproxen and tablet excipients using differential scanning calorimetry,(1990) 673-683; DOI: 10.3109/03639049009104410.
  8. A. T. Serajuddin, A. B. Thakur, R. N. Ghoshal, M. G. Fakes, S. A. Ranadive, K. R. Morris and S. A. Varia, Selection of solid dosage form composition through drug-excipient compatibility testing,(1999) 696-704.
  9. L. Gu, R. G. Strickley, L. H. Chi and Z. T. Chowhan, Drug-excipient incompatibility studies of the dipeptide angiotensin-converting enzyme inhibitor, moexipril hydrochloride: dry powder vs wet granulation,(1990) 379-383.
  10. J. F. McLeod, Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent,(2004) 97-120.
  11. M. E. Sangalli, P. Giunchedi, P. Colombo, U. Conte, A. Gazzaniga and A. La Manna, Cross-linked sodium carboxymethylcellulose as a carrier for dissolution rate improvement of drugs,(1989) 242-247.
  12. , USP Convention, Rockville 2007.
  13. U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research, Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, FDA CDER, Rockville (MD) 1997; Guidances/UCM070237; access date May 15, 2010.
  14. J. W. Moore and H. H. Flanner, Mathematical comparison of dissolution profiles,(1996) 64-74.
  15. A. Smith, Use of thermal analysis in predicting drug-excipient interactions,(1982) 559-561.
  16. T. Durig and A. R. Fassihi, Identification of stabilizing and destabilizing effects of excipient-drug interactions in solid dosage form design,(1993) 161-170.
DOI: https://doi.org/10.2478/v10007-011-0016-4 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 237 - 247
Published on: Jun 17, 2011
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2011 Nihar Pani, Lila Nath, Sujata Acharya, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.